US congressional report knocks FDA approval of Alzheimer's drug
INSUBCONTINENT EXCLUSIVE:
WASHINGTON - The United States Food and Drug Administrations approval procedure for a questionable drug used to deal with Alzheimers was
rife with abnormalities, a congressional report said Thursday.
